The Interaction of Dyslipidaemia with Glycaemia in an Adult Population Study

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2019 Mar 29

PMID 30918867

Citations 3

Authors

Sarah Cuschieri

Josanne Vassallo

Neville Calleja

Christopher Barbara

Julian Mamo

Affiliations

Soon will be listed here.

Abstract

Purpose: Individuals with dysglycaemic are prone to dyslipidaemia. Understanding the dyslipidaemic status of dysglycaemic individuals is essential for monitoring and early prevention. The aim was to assess the control of lipidaemia by glycaemic status in a representative adult population.

Methods: A retrospective health examination survey was performed on a sample of adults ( = 3947) in Malta in 2014-6. Sociodemographic data, biochemistry blood tests and anthropometric measurements were gathered. Statistical analysis was performed to evaluate the lipidaemic status and its control across the glycaemic spectrum (normoglycemic, impaired fasting glucose individuals, new diabetics and known diabetics).

Results: The prevalence of a was 7.75% (CI 95%: 6.69-8.63), among whom 6.97% (CI 95%: 6.21-7.81) were naïve dyslipidaemic. A progressive elevation in both LDL-C and total cholesterol but not triglycerides was present among a individuals across the glycaemic spectrum. was present in 19.26% (CI 95%: 18.05-20.52) of the total general population and in 46.59% (CI 95%: 40.49-52.69%) of known diabetics. Most individuals irrespective of lipid status were normoglycaemic.

Conclusions: Dyslipidaemia occurs in the presence of insulin resistance. Dyslipidaemia predominated in the normoglycaemic state irrespective of statins use, indicating the need to manage dyslipidaemia prior to dysglycaemia.

Citing Articles

Insight into the Occurrence of Common Non-communicable Diseases at a Population Level and the Potential Impact During the Coronavirus Pandemic - a Need for a Syndemic Healthcare Approach?.

Cuschieri S, Grech S SN Compr Clin Med. 2021; 3(12):2393-2400.

PMID: 34568765 PMC: 8455231. DOI: 10.1007/s42399-021-01064-2.

Adherence to the Mediterranean Diet in Maltese Adults.

Cuschieri S, Libra M Int J Environ Res Public Health. 2020; 18(1).

PMID: 33375013 PMC: 7792766. DOI: 10.3390/ijerph18010010.

COVID-19 panic, solidarity and equity-the Malta exemplary experience.

Cuschieri S Z Gesundh Wiss. 2020; 30(2):459-464.

PMID: 32837836 PMC: 7261042. DOI: 10.1007/s10389-020-01308-w.

References

Goldberg I . Clinical review 124: Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001; 86(3):965-71. DOI: 10.1210/jcem.86.3.7304. View

Buse K, Tanaka S, Hawkes S . Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure. Global Health. 2017; 13(1):34. PMC: 5472958. DOI: 10.1186/s12992-017-0255-3. View

Chehade J, Gladysz M, Mooradian A . Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs. 2013; 73(4):327-39. DOI: 10.1007/s40265-013-0023-5. View

Betteridge D . Diabetic dyslipidaemia. Eur J Clin Invest. 1999; 29 Suppl 2:12-6. DOI: 10.1046/j.1365-2362.1999.00002.x. View

Chen S, Lee W, Liang T, Liao I . Factors associated with gender differences in medication adherence: a longitudinal study. J Adv Nurs. 2014; 70(9):2031-2040. DOI: 10.1111/jan.12361. View

Ali F, Jamil H, Anwar S, Wajid N . Characterization of lipid parameters in diabetic and non-diabetic atherosclerotic patients. J Geriatr Cardiol. 2015; 12(1):37-43. PMC: 4308457. DOI: 10.11909/j.issn.1671-5411.2015.01.005. View

Avramoglu R, Basciano H, Adeli K . Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta. 2006; 368(1-2):1-19. DOI: 10.1016/j.cca.2005.12.026. View

Cuschieri S, Vassallo J, Calleja N, Pace N, Abela J, Ali B . The diabesity health economic crisis-the size of the crisis in a European island state following a cross-sectional study. Arch Public Health. 2016; 74:52. PMC: 5151145. DOI: 10.1186/s13690-016-0164-6. View

. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2015; 39 Suppl 1:S13-22. DOI: 10.2337/dc16-S005. View

10.

Cuschieri S, Vassallo J, Calleja N, Pace N, Mamo J . The Effects of Socioeconomic Determinants on Hypertension in a Cardiometabolic At-Risk European Country. Int J Hypertens. 2017; 2017:7107385. PMC: 5592416. DOI: 10.1155/2017/7107385. View

11.

Granger B, Bosworth H . Medication adherence: emerging use of technology. Curr Opin Cardiol. 2011; 26(4):279-87. PMC: 3756138. DOI: 10.1097/HCO.0b013e328347c150. View

12.

Wierzbicki A, Poston R, Ferro A . The lipid and non-lipid effects of statins. Pharmacol Ther. 2003; 99(1):95-112. DOI: 10.1016/s0163-7258(03)00055-x. View

13.

Bonetti P, Lerman L, Napoli C, Lerman A . Statin effects beyond lipid lowering--are they clinically relevant?. Eur Heart J. 2003; 24(3):225-48. DOI: 10.1016/s0195-668x(02)00419-0. View

14.

Vanelli M, Pedan A, Liu N, Hoar J, Messier D, Kiarsis K . The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses. Clin Ther. 2010; 31(11):2628-52. DOI: 10.1016/j.clinthera.2009.11.028. View

15.

Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes E . The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012; 380(9841):581-90. PMC: 3437972. DOI: 10.1016/S0140-6736(12)60367-5. View

16.

Sattar N . Revisiting the links between glycaemia, diabetes and cardiovascular disease. Diabetologia. 2013; 56(4):686-95. DOI: 10.1007/s00125-012-2817-5. View

17.

Cannon C, Steinberg B, Murphy S, Mega J, Braunwald E . Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol. 2006; 48(3):438-45. DOI: 10.1016/j.jacc.2006.04.070. View

18.

Sundbom L, Bingefors K . Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish survey. Pharm Pract (Granada). 2013; 10(4):207-21. PMC: 3780500. DOI: 10.4321/s1886-36552012000400005. View

19.

Daboul M . A study measuring the effect of high serum triglyceride and cholesterol on glucose elevation in human serum. Oman Med J. 2011; 26(2):109-13. PMC: 3191678. DOI: 10.5001/omj.2011.27. View

20.

Inzucchi S, Amatruda J . Lipid management in patients with diabetes: translating guidelines into action. Diabetes Care. 2003; 26(4):1309-11. DOI: 10.2337/diacare.26.4.1309. View